The loss of heterozygosity and acquisition of a secondary mutation restoring the open reading frame suggest that this somatic BRCA2 mutation (c.5446_5449delCTAG) was the driver for tumour formation (i.e. is a pathogenic mutation) and the cause of the initial platinum sensitivity. This evidence concerns the gene BRCA2 and neoplasm.